OLYS Pharma SRL
The score of OLYS Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +252 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
OLYS Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 01 Aug 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
OLYS Pharma's financial analysis
- Solvency56.0%sector median: 42.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of OLYS Pharma
OLYS Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0754.895.372
- VAT number
- BE0754895372
- Peppol
- Registered · 0208:0754895372 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Sep 2020
- Registered office
- 1310 La Hulpe
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
OLYS Pharma (SRL) has been based in La Hulpe since 2020, active in: manufacture of medicaments. For 2025, it reports a net profit of 14,126 € and equity of 578,974 €; its revenue is not published. Its solvency stands at 56.0%, above the median of its sector (42.6%).
Companies similar to OLYS Pharma
Companies in the same business, of comparable size and area, outside its group.
- Plant Bio Technologies Manufacture of basic pharmaceutical products Ghent · balance sheet €1.04m
- Galenicap Manufacture of basic pharmaceutical products Ixelles · balance sheet €1.47m
- Equibor Manufacture of basic pharmaceutical products Manage · balance sheet €1.12m
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- XeroThera Europe Manufacture of basic pharmaceutical products Liège · balance sheet 820,359 €
- Temmune Therapeutics Manufacture of pharmaceutical preparations Mechelen · balance sheet €3.43m
- DeuterOncology Manufacture of basic pharmaceutical products Liège · balance sheet 688,028 €
Frequently asked questions about OLYS Pharma
What is the revenue of OLYS Pharma?
OLYS Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of OLYS Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0754895372 for OLYS Pharma, if the company is VAT-registered. Its company number (CBE) is 0754.895.372.
Where is the registered office of OLYS Pharma?
According to the CBE register, the registered office of OLYS Pharma is in 1310 La Hulpe.
What is the equity of OLYS Pharma?
At the close of the 2025 financial year, the equity of OLYS Pharma amounts to 578,974 €, a solvency of 56.0% of total assets.
Who manages OLYS Pharma?
The register lists 3 active mandates at OLYS Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of OLYS Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →